The last time I spoke about Absci Corporation (ABSI), it was in a Seeking Alpha article entitled "Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile." The hope here ...
The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inmune Bio , AbSci and Ionis Pharmaceuticals with bullish sentiments. TipRanks' Pr ...
Absci Corp (NASDAQ:ABSI) shares are trading lower by 9.4% to $4.46 Wednesday afternoon after the company announced an offering of 16.7 million shares at $4.50 per share. The underwriters have an ...
VANCOUVER, Wash., July 24, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI) (“Absci”), a clinical-stage biopharmaceutical company advancing potential breakthrough therapeutics designed with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results